Redeye sustains its positive view of CombinedX following a solid Q1 report. While organic growth was flat – a decent number in the current market – the EBIT margin remained solid. Management sees a mixed market, which it expects will remain unchanged in 2024. We leave our forecasts roughly intact.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

CombinedX - Solid Start to 2024 – Expects Current Market Conditions to Remain

© Modular Finance, source Nordic Press Releases